New-Onset Gastrointestinal Polyposis in a 60-Year-Old Man with Cronkhite-Canada Syndrome

    October 2013 in “ Gastroenterology
    Mohannad Dugum, Ibrahim A. Hanouneh, Abdullah Shatnawei
    Image of study
    TLDR A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.
    A 60-year-old man with a history of diarrhea, weight loss, and various ectodermal changes was diagnosed with Cronkhite-Canada syndrome (CCS), a rare, nonhereditary disorder characterized by gastrointestinal polyposis, diarrhea, weight loss, hypogeusia, onychodystrophy, alopecia, and skin hyperpigmentation. His symptoms improved after treatment with prednisone and azathioprine. CCS is associated with a high mortality rate and increased risk of colorectal cancer. The patient's abdominal CT and endoscopies revealed thickening of the gastric body and antrum, as well as numerous polyps and nodular mucosa in the colon. Biopsies indicated hyperplastic polyps and focal colitis. CCS affects all ethnic groups, has a slight male predominance, and the mean age of onset is 59 years. The polyps are typically hamartomatous and nonneoplastic, but dysplastic changes can occur, leading to a 25% lifetime risk of colorectal cancer. The exact etiology of CCS is unknown, but an autoimmune mechanism is proposed. Treatment is not standardized due to the rarity of CCS, but steroids and nutritional supplements are commonly used, with azathioprine for relapses. Resection may be necessary for any remaining polyps, especially if dysplastic changes are detected.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 2 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

      community What are these spots on my scalp

      in Treatment  51 upvotes 2 months ago
      A user noticed non-itchy, non-bleeding spots on their scalp while experiencing hair loss. Replies suggest the spots are likely sunspots or liver spots and recommend seeing a dermatologist; hair loss is attributed to male pattern baldness.

      community Why is no one pointing out dandruff as the number 1 evidence/symptom of MPB?

      in Chat  55 upvotes 1 year ago
      The post discusses the theory that persistent dandruff in areas prone to hair loss could be a sign of hair follicles dying due to DHT, indicating balding. The responses vary, with some users noting improvements in dandruff and hair loss with treatments like Dutasteride, while others experienced hair loss without dandruff.

      community Comprehensive Microneedling Guide

      in Microneedling  287 upvotes 2 years ago
      Microneedling for hair restoration involves daily use of a 0.3 mm device and weekly use of a 0.5 mm device. Combining microneedling with Minoxidil can enhance hair growth.

      community Vitamin C and hair growth PH levels

      in Product  34 upvotes 2 years ago
      The conversation is about using vitamin C and Magnesium L-Threonate for hair growth by reducing DHT binding to dermal papilla cells. The original post about vitamin C's pH levels and sebum control was possibly removed by a moderator.

    Similar Research

    5 / 1000+ results